Cargando…
Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447227/ https://www.ncbi.nlm.nih.gov/pubmed/28611733 http://dx.doi.org/10.3389/fmicb.2017.00888 |
_version_ | 1783239285118337024 |
---|---|
author | Fernández de Larrea-Baz, Nerea Michel, Angelika Romero, Beatriz Pérez-Gómez, Beatriz Moreno, Victor Martín, Vicente Dierssen-Sotos, Trinidad Jiménez-Moleón, José J. Castilla, Jesús Tardón, Adonina Ruiz, Irune Peiró, Rosana Tejada, Antonio Chirlaque, María D. Butt, Julia A. Olmedo-Requena, Rocío Gómez-Acebo, Inés Linares, Pedro Boldo, Elena Castells, Antoni Pawlita, Michael Castaño-Vinyals, Gemma Kogevinas, Manolis de Sanjosé, Silvia Pollán, Marina del Campo, Rosa Waterboer, Tim Aragonés, Nuria |
author_facet | Fernández de Larrea-Baz, Nerea Michel, Angelika Romero, Beatriz Pérez-Gómez, Beatriz Moreno, Victor Martín, Vicente Dierssen-Sotos, Trinidad Jiménez-Moleón, José J. Castilla, Jesús Tardón, Adonina Ruiz, Irune Peiró, Rosana Tejada, Antonio Chirlaque, María D. Butt, Julia A. Olmedo-Requena, Rocío Gómez-Acebo, Inés Linares, Pedro Boldo, Elena Castells, Antoni Pawlita, Michael Castaño-Vinyals, Gemma Kogevinas, Manolis de Sanjosé, Silvia Pollán, Marina del Campo, Rosa Waterboer, Tim Aragonés, Nuria |
author_sort | Fernández de Larrea-Baz, Nerea |
collection | PubMed |
description | Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ≥4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71–1.16). Among H. pylori seropositive subjects, seropositivity to Cagδ showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified. |
format | Online Article Text |
id | pubmed-5447227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54472272017-06-13 Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain Fernández de Larrea-Baz, Nerea Michel, Angelika Romero, Beatriz Pérez-Gómez, Beatriz Moreno, Victor Martín, Vicente Dierssen-Sotos, Trinidad Jiménez-Moleón, José J. Castilla, Jesús Tardón, Adonina Ruiz, Irune Peiró, Rosana Tejada, Antonio Chirlaque, María D. Butt, Julia A. Olmedo-Requena, Rocío Gómez-Acebo, Inés Linares, Pedro Boldo, Elena Castells, Antoni Pawlita, Michael Castaño-Vinyals, Gemma Kogevinas, Manolis de Sanjosé, Silvia Pollán, Marina del Campo, Rosa Waterboer, Tim Aragonés, Nuria Front Microbiol Microbiology Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ≥4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71–1.16). Among H. pylori seropositive subjects, seropositivity to Cagδ showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified. Frontiers Media S.A. 2017-05-29 /pmc/articles/PMC5447227/ /pubmed/28611733 http://dx.doi.org/10.3389/fmicb.2017.00888 Text en Copyright © 2017 Fernández de Larrea-Baz, Michel, Romero, Pérez-Gómez, Moreno, Martín, Dierssen-Sotos, Jiménez-Moleón, Castilla, Tardón, Ruiz, Peiró, Tejada, Chirlaque, Butt, Olmedo-Requena, Gómez-Acebo, Linares, Boldo, Castells, Pawlita, Castaño-Vinyals, Kogevinas, de Sanjosé, Pollán, del Campo, Waterboer and Aragonés. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Fernández de Larrea-Baz, Nerea Michel, Angelika Romero, Beatriz Pérez-Gómez, Beatriz Moreno, Victor Martín, Vicente Dierssen-Sotos, Trinidad Jiménez-Moleón, José J. Castilla, Jesús Tardón, Adonina Ruiz, Irune Peiró, Rosana Tejada, Antonio Chirlaque, María D. Butt, Julia A. Olmedo-Requena, Rocío Gómez-Acebo, Inés Linares, Pedro Boldo, Elena Castells, Antoni Pawlita, Michael Castaño-Vinyals, Gemma Kogevinas, Manolis de Sanjosé, Silvia Pollán, Marina del Campo, Rosa Waterboer, Tim Aragonés, Nuria Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain |
title | Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain |
title_full | Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain |
title_fullStr | Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain |
title_full_unstemmed | Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain |
title_short | Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain |
title_sort | helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in spain |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447227/ https://www.ncbi.nlm.nih.gov/pubmed/28611733 http://dx.doi.org/10.3389/fmicb.2017.00888 |
work_keys_str_mv | AT fernandezdelarreabaznerea helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT michelangelika helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT romerobeatriz helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT perezgomezbeatriz helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT morenovictor helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT martinvicente helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT dierssensotostrinidad helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT jimenezmoleonjosej helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT castillajesus helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT tardonadonina helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT ruizirune helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT peirorosana helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT tejadaantonio helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT chirlaquemariad helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT buttjuliaa helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT olmedorequenarocio helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT gomezaceboines helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT linarespedro helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT boldoelena helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT castellsantoni helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT pawlitamichael helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT castanovinyalsgemma helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT kogevinasmanolis helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT desanjosesilvia helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT pollanmarina helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT delcamporosa helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT waterboertim helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain AT aragonesnuria helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain |